375 related articles for article (PubMed ID: 24176522)
1. Serum endocan levels as a marker of disease activity in patients with Behçet disease.
Balta I; Balta S; Koryurek OM; Demirkol S; Mikhailidis DP; Celik T; Cakar M; Kucuk U; Eksioglu M; Kurt YG
J Am Acad Dermatol; 2014 Feb; 70(2):291-6. PubMed ID: 24176522
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Endocan Serum Level in Patients with Behçet Disease: Relation to Disease Activity and Carotid Intima Media Thickness.
Hassan WA; Behiry EG; Abdelshafy S; Salem T; Baraka EA
Egypt J Immunol; 2020 Jan; 27(1):129-139. PubMed ID: 33180395
[TBL] [Abstract][Full Text] [Related]
3. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease.
Balta I; Balta S; Demirkol S; Mikhailidis DP; Celik T; Akhan M; Kurt O; Kurt YG; Aydin I; Kilic S
Br J Dermatol; 2013 Nov; 169(5):1066-70. PubMed ID: 23889284
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated phospholipase A2 level in patients with Behçet's disease.
Örem A; Yayli S; Arıca DA; Akcan B; Yücesan FB; Bahadir S
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e289-93. PubMed ID: 22755553
[TBL] [Abstract][Full Text] [Related]
6. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
7. Endocan--a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study.
Balta S; Mikhailidis DP; Demirkol S; Ozturk C; Kurtoglu E; Demir M; Celik T; Turker T; Iyisoy A
Angiology; 2014 Oct; 65(9):773-7. PubMed ID: 24402320
[TBL] [Abstract][Full Text] [Related]
8. Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and toxic epidermal necrolysis.
Syed D; Iqbal O; Mosier M; Mitchell R; Hoppensteadt D; Bouchard C; Fareed J; Gamelli R
Int Angiol; 2015 Oct; 34(5):483-8. PubMed ID: 25394955
[TBL] [Abstract][Full Text] [Related]
9. Endocan measurement for the postmortem diagnosis of sepsis.
Palmiere C; Augsburger M
Leg Med (Tokyo); 2014 Jan; 16(1):1-7. PubMed ID: 24262651
[TBL] [Abstract][Full Text] [Related]
10. Inflammation-induced increases in plasma endocan levels are associated with endothelial dysfunction in humans in vivo.
Cox LA; van Eijk LT; Ramakers BP; Dorresteijn MJ; Gerretsen J; Kox M; Pickkers P
Shock; 2015 Apr; 43(4):322-6. PubMed ID: 25565643
[TBL] [Abstract][Full Text] [Related]
11. Endocan--the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease.
Pawlak K; Mysliwiec M; Pawlak D
Clin Biochem; 2015 Apr; 48(6):425-30. PubMed ID: 25617664
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum endothelial cell specific molecule-1 (endocan) levels as a biomarker in patients with pulmonary thromboembolism.
Güzel A; Duran L; Köksal N; Torun AC; Alaçam H; Ekiz BC; Murat N
Blood Coagul Fibrinolysis; 2014 Apr; 25(3):272-6. PubMed ID: 24509328
[TBL] [Abstract][Full Text] [Related]
13. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up.
Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of serum endocan levels in infection.
Seo K; Kitazawa T; Yoshino Y; Koga I; Ota Y
PLoS One; 2015; 10(4):e0123358. PubMed ID: 25894539
[TBL] [Abstract][Full Text] [Related]
15. Elevated Human Endothelial Cell-Specific Molecule-1 Level and Its Association With Coronary Artery Disease in Patients With Hypertension.
Xiong C; Zhao ZW; Chen ZY; Wu LZ; Luo YK; Hu FD; Lin CG; Chen LL
J Investig Med; 2015 Oct; 63(7):867-70. PubMed ID: 26200037
[TBL] [Abstract][Full Text] [Related]
16. Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study.
Kose M; Emet S; Akpinar TS; Kocaaga M; Cakmak R; Akarsu M; Yuruyen G; Arman Y; Tukek T
Angiology; 2015 Sep; 66(8):727-31. PubMed ID: 25168956
[TBL] [Abstract][Full Text] [Related]
17. Higher Serum Endocan Level Is Associated with Alzheimer Disease.
Varan HD; Guner G; Kizilarslanoglu MC; Sumer F; Dogrul RT; Sagir A; Ozsurekci C; Caliskan H; Balci C; Aycicek GS; Akbiyik F; Halil M; Cankurtaran M; Yavuz BB
Dement Geriatr Cogn Disord; 2017; 44(5-6):303-310. PubMed ID: 29393258
[TBL] [Abstract][Full Text] [Related]
18. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
19. Elevated oxidative stress markers and its relationship with endothelial dysfunction in Behçet disease.
Acikgoz N; Ermiş N; Yağmur J; Cansel M; Karincaoğlu Y; Ataş H; Cuglan B; Barutcu I; Pekdemir H; Özdemir R
Angiology; 2011 May; 62(4):296-300. PubMed ID: 20947865
[TBL] [Abstract][Full Text] [Related]
20. Endocan, TGF-beta, and ADMA as Risk Factors for Endothelial Dysfunction and Possible Vascular Disease in Patients with Subclinical Hypothyroidism.
Arpaci D; Karakece E; Tocoglu AG; Ergenc H; Gurol G; Ciftci IH; Tamer A
Ann Clin Lab Sci; 2016 Dec; 46(6):601-607. PubMed ID: 27993872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
